Skip to main content

Table 3 Change after 3 and 6 months under therapy, all patients

From: The MCP2 and the wrist plus two extensor compartments are the most affected and responsive joints/tendons out of the US7 score in patients with rheumatoid arthritis-an observational study

Joint

Region

Mode

n

p-value

Baseline to 3 months (T0-T1)

3 to 6 months (T1-T2)

Baseline to 6 months (T0-T2)

Synovitis

Wrist

Dorsal

GS

401

< 0.001b

1.000b

< 0.001a

Palmar

GS

398

0.022b

0.770b

< 0.001a

Ulnar

GS

393

< 0.001b

1.000b

< 0.001a

Dorsal

PD

354

0.002b

1.000b

< 0.001a

Palmar

PD

348

0.146b

1.000b

< 0.001a

Ulnar

PD

343

0.010b

1.000b

< 0.001a

MCP2

Palmar

GS

401

0.008b

0.574b

< 0.001a

Dorsal

PD

286

0.121b

1.000b

< 0.001a

Palmar

PD

349

0.093b

0.635b

< 0.001a

MCP3

Palmar

GS

397

0.004b

1.000b

< 0.001a

Dorsal

PD

283

0.424b

1.000b

< 0.001a

Palmar

PD

343

0.326b

0.991b

< 0.001a

PIP2

Palmar

GS

399

0.058b

1.000b

< 0.001a

Dorsal

PD

250

0.943b

1.000b

< 0.001a

Palmar

PD

325

0.364b

1.000b

< 0.001a

PIP3

Palmar

GS

397

0.030b

1.000b

< 0.001a

Dorsal

PD

253

0.799b

1.000b

< 0.001a

Palmar

PD

324

1.000b

1.000b

0.002a

MTP2

Dorsal

GS

392

0.131b

1.000b

0.002a

Dorsal

PD

303

0.313b

1.000b

< 0.001a

MTP5

Dorsal

GS

390

0.033b

1.000b

< 0.001a

Dorsal

PD

296

0.565b

1.000b

< 0.001a

Tenosynovitis/paratenonitis

Wrist

EDC

GS

392

< 0.001d

1.000d

< 0.001c

EDC

PD

299

0.891d

1.000d

0.003c

FDS/P

GS

393

< 0.001d

1.000d

< 0.001c

FDS/P

PD

295

1.000d

1.000d

0.041c

ECU

GS

391

0.002d

0.741d

< 0.001c

ECU

PD

295

0.853d

1.000d

0.001c

MCP level

ET2

GS

393

< 0.001d

0.805d

< 0.001c

ET2

PD

259

1.000d

1.000d

< 0.001c

ET3

GS

391

< 0.001d

1.000d

< 0.001c

ET3

PD

257

1.000d

1.000d

0.012c

FT2

GS

392

< 0.001d

0.333d

< 0.001c

FT2

PD

248

-

-

0.390c

FT3

GS

384

< 0.001d

0.715d

< 0.001c

FT3

PD

242

1.000d

1.000d

0.015c

  1. P-values depicting change of severity (grades) over time (the underlying data incl. effect sizes can be found in supplementary tables 3.1 and 3.2)
  2. aFriedman test, bDunn test as post-hoc test, cCochrane-Q test (GS) and Friedman test (PD) resp.; dMcNemar test (GS) and Dunn test (PD) as post-hoc tests resp.; GS greyscale, PD power Doppler
  3. MCP metacarpophalangeal, PIP proximal interphalangeal, MTP metatarsophalangeal, FT/ET2 flexor/extensor tendon on MCP2 level, FT/ET3 flexor/extensor tendon on MCP3 level, FDS/P flexor digitorum superficialis/profundus tendon, EDC extensor digitorum communis tendon (extensor compartment lV), ECU extensor carpi ulnaris tendon (extensor compartment Vl)